Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Regular physical activity is widely recognized for its benefits to physical health, including improved heart function and ...

The following is a summary of “Bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

Functional subpopulations of β-cells emerge to control pulsative insulin secretion in the pancreatic islets of mice through calcium oscillations.

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders.